CVS Health Corp. (CVS) Stock

About CVS Health Corp.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp. is led by CEO J. David Joyner, employs 300,000 people, headquartered in Woonsocket, US, publicly traded since 1996.

CVS Health Corp. (CVS) stock trades at $105.92 with a market capitalization of $135.15B. The stock is valued at a price-to-earnings (P/E) ratio of 44.16, price-to-book of 1.65, price-to-sales of 0.31. Over the past 52 weeks the stock has ranged between $58.35 and $110.60, and currently trades 4.2% below its 52-week high. It pays a dividend yielding 2.64%.

On profitability, CVS Health Corp. generates a return on equity (ROE) of 3.75%, return on capital employed of 13.78%, an operating margin of 1.46%, a net profit margin of 0.72%.

In its most recent fiscal year, CVS Health Corp. reported annual revenue of $402.1B, net profit of $1.8B, revenue has compounded at 8.4% a year over the last five years, profit at -24.4% a year.

The balance sheet shows a debt-to-equity ratio of 1.01, a current ratio of 0.84, total assets of $261.1B, $8.5B in cash and equivalents.

CVS has an average daily trading volume of 8,312,678 shares, a beta of 0.62 (less volatile than the overall market).

Official website: www.cvshealth.com